A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 430 participants.
Also called NCT02890160
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 430 participants
- Registry
-
NCT02890160
-
- Other papers using this trial's data
- Thinner Strut Sirolimus-Eluting BRS Versus EES in Patients With Coronary Artery Disease: FUTURE-II Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02890160. Randomized; single masking; primary purpose treatment. Start 2017-08-24 (actual); primary completion 2020-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II
- Acronym
- FUTURE-II
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Firesorb
- Intervention (Device)
- XIENCE
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
Record details
- Record id
cardio:ct-nct02890160- Content hash
bf7179f0c8a6403ed7d5de936576427e81ec588707f2b5ff806d967ea6abf640